Literature DB >> 7247627

Increased whole blood serotonin concentrations in chronic schizophrenic patients.

L E DeLisi, L M Neckers, D R Weinberger, R J Wyatt.   

Abstract

Whole blood serotonin concentrations were studied in 33 chronic schizophrenic patients who previously had computed tomographic (CT) brain scans and in 23 healthy volunteers. The chronic schizophrenic patients had a mean serotonin concentration significantly higher than that of the controls. The patients were subcategorized into a group with abnormal CT scan findings (enlargement of cerebral ventricles, cerebral atrophy, or both) and a group with normal CT scans. The patients with abnormal CT scans had significantly higher serotonin concentrations when compared with schizophrenics with normal CT scans and with controls. The chronic schizophrenic patients with normal CT scans did not have significantly elevated serotonin concentrations compared with controls. Furthermore, ventricular size in the total group was significantly correlated with serotonin concentration.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247627     DOI: 10.1001/archpsyc.1981.01780310047004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  7 in total

1.  Differential regulation of observational fear and neural oscillations by serotonin and dopamine in the mouse anterior cingulate cortex.

Authors:  Byung Sun Kim; Junghee Lee; Minji Bang; Bo Am Seo; Arshi Khalid; Min Whan Jung; Daejong Jeon
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

2.  Integrin β3 Haploinsufficiency Modulates Serotonin Transport and Antidepressant-Sensitive Behavior in Mice.

Authors:  Matthew Mazalouskas; Tammy Jessen; Seth Varney; James S Sutcliffe; Jeremy Veenstra-VanderWeele; Edwin H Cook; Ana M D Carneiro
Journal:  Neuropsychopharmacology       Date:  2015-02-16       Impact factor: 7.853

3.  Serum amino acid profiles and dopamine in schizophrenic patients and healthy subjects: Window to the brain?

Authors:  M L Rao; B Strebel; G Gross; G Huber
Journal:  Amino Acids       Date:  1992-02       Impact factor: 3.520

4.  Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.

Authors:  D L Ceulemans; Y G Gelders; M L Hoppenbrouwers; A J Reyntjens; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 5.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  Antibodies as molecular probes in neurobiology. Identification of chemically defined neurons and synapses in tissues and tissue cultures.

Authors:  J Pecci Saavedra; A Brusco; J J López-Costa; L A Gómez; E M López
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

Review 7.  Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.

Authors:  S Grant; A Fitton
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.